Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urea Cycle01:23

Urea Cycle

43.3K
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
43.3K
Overview of Cell Death01:30

Overview of Cell Death

6.2K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
6.2K
Autophagic Cell Death01:18

Autophagic Cell Death

2.9K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
2.9K
Necrosis01:16

Necrosis

3.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.9K
Apoptosis01:30

Apoptosis

10.5K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
10.5K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

3.3K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GLP-1 receptor agonists and weight-loss strategies for individuals with obesity and hip or knee osteoarthritis: a scoping review.

British journal of sports medicine·2026
Same author

Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial.

British journal of haematology·2026
Same author

Ensemble learning for predicting the damped response of granular materials and interpretation through feature importance analysis.

The Journal of the Acoustical Society of America·2026
Same author

Consensus versus Outcome-based Definitions of Acute-on-chronic Liver Failure: Implications for Risk Stratification and Case Identification.

Journal of clinical and translational hepatology·2026
Same author

Building a Mississippi Military-Civilian Surgical Partnership for Readiness and Community Service.

Military medicine·2026
Same author

Blood multiomics reveal a dysregulated lipid mediator-mitochondrial network associated with the outcome of advanced cirrhosis.

Nature communications·2026
Same journal

Erratum for the Research Article "Assessing the health risks of rice cadmium content standards in China" by H. Chu <i>et al</i>.

Science advances·2026
Same journal

Erratum for the Research Article "Developmental regulation of Erk signaling by mitotic kinases" by F. Chen <i>et al</i>.

Science advances·2026
Same journal

Magnetically levitated metasurface enabling tangible and bidirectional human-machine interaction.

Science advances·2026
Same journal

A general photoinduced manganese-catalyzed platform for the sequential difunctionalization of [1.1.1]propellane.

Science advances·2026
Same journal

Turning sound and force into light with AlN:Mn<sup>2+</sup> mechanoluminescence.

Science advances·2026
Same journal

Extreme dominance of Earth-origin heavy ions in the intense ring current near the Earth during the May 2024 super geomagnetic storm.

Science advances·2026
See all related articles

Related Experiment Video

Updated: May 23, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP &#8212; Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
06:12

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

1.6K

Hyperammonemia induces programmed liver cell death.

Annarein J C Kerbert1,2, Cornelius Engelmann1,3, Abeba Habtesion1

  • 1Liver Failure Group, Institute for Liver and Digestive Health, University College London, Royal Free Campus, London, UK.

Science Advances
|March 7, 2025
PubMed
Summary
This summary is machine-generated.

Hyperammonemia causes liver damage, fibrogenesis, and cell death by disrupting the urea cycle. Inhibiting RIPK1 and TLR4 protects the liver from these effects, offering potential therapeutic targets for liver disease.

More Related Videos

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
10:36

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons

Published on: November 6, 2017

8.0K
Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
12:44

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells

Published on: October 11, 2012

23.1K

Related Experiment Videos

Last Updated: May 23, 2025

Author Spotlight: THP-1 Macrophage Response to LPS/ATP &#8212; Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
06:12

Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum

Published on: May 3, 2024

1.6K
Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
10:36

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons

Published on: November 6, 2017

8.0K
Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
12:44

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells

Published on: October 11, 2012

23.1K

Area of Science:

  • Hepatology
  • Cellular Biology
  • Biochemistry

Background:

  • Hyperammonemia is prevalent in liver cirrhosis and linked to hepatic encephalopathy.
  • The specific hepatotoxic mechanisms of hyperammonemia remain poorly understood.
  • Understanding these mechanisms is crucial for managing liver disease progression.

Purpose of the Study:

  • To characterize the hepatotoxic effects of chronic hyperammonemia.
  • To investigate the role of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and Toll-like receptor 4 (TLR4) in hyperammonemia-induced liver injury.
  • To explore therapeutic potential of inhibiting RIPK1 and TLR4.

Main Methods:

  • Utilized a mouse model of chronic hyperammonemia without pre-existing liver disease.
  • Examined liver fibrogenesis, necroptotic cell death, and urea cycle function.
  • Investigated the effects of RIPK1 and TLR4 inhibition in various rodent models of hyperammonemia.

Main Results:

  • Chronic hyperammonemia induced liver fibrogenesis and necroptotic cell death in mice.
  • Hyperammonemia led to urea cycle dysregulation, including enzyme downregulation and metabolite accumulation.
  • Inhibition of RIPK1 and TLR4 ameliorated liver injury and reduced ammonia levels in relevant models.

Conclusions:

  • Hyperammonemia drives liver fibrogenesis and RIPK1-mediated cell death, coupled with urea cycle dysfunction.
  • Targeting RIPK1 and TLR4 demonstrates protective effects against hyperammonemia-induced liver injury.
  • RIPK1 and TLR4 inhibition represent potential therapeutic strategies for hyperammonemia and chronic liver disease progression.